The current Coronavirus Disease 2019 (COVID-19) pandemic, with more than 111 million
reported cases and 2,500,000 deaths worldwide (mortality rate currently estimated at 2.2%), is …

The rapid spread of SARS-CoV-2 variants has quickly spanned doubts and the fear about
their ability escape vaccine protection. Some of these variants initially identified in caged were …

Background In Marseille, France, following a first severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) outbreak in March–May 2020, a second epidemic phase occurred …

Objectives Surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
genomic epidemiology led us to detect several variants since summer 2020. We report the …

A novel severe acute respiratory syndrome coronavirus, SARS-CoV-2, emerged in China in
December 2019 and spread worldwide, causing more than 1.3 million deaths in 11 months. …

β-lactamase enzymes have generated significant interest due to their ability to confer
resistance to the most commonly used family of antibiotics in human medicine. Among these …

Nonribosomal peptides are assemblages, including antibiotics, of canonical amino acids
and other molecules. β-lactam antibiotics act on bacterial cell walls and can be cleaved by β-…

Introduction The SARS-CoV-2 pandemic has been associated with the occurrence since
summer 2020 of several viral variants that overlapped or succeeded each other in time. Those …

The discovery of Acanthamoeba polyphaga Mimivirus, the first isolated giant virus of amoeba,
challenged the historical hallmarks defining a virus. Giant virion sizes are known to reach …

Urinary tract infections are among the most common reasons for antimicrobial treatment,
and early diagnosis could have a significant impact by enabling rapid administration of the …